Performance Summary
Past performance is not a reliable indicator of future performance
Source: Internal CI data reports, April 30, 2025
Inception Date: 2 July 2019
*Annualised
^Partial Year
Investment Objective
The objective of the Fund is to generate long term returns by investing in a range of listed securities. The Fund will invest in a portfolio of stocks that meet CI's guidelines of founder led, family linked or employee owned companies.
The Fund will be constructed with limited reference to the Benchmark and therefore the returns of the Fund may significantly vary from the Benchmark returns. The Fund has a long term investment horizon.
It is a long only portfolio of 15-30 stocks.
$100k Invested Since Inception (net)
Past performance is not a reliable indicator of future performance
Source: Internal CI data reports, April 30, 2025
Since Inception Returns (Net)
Portfolio Snapshot
Source: Internal CI data reports, April 30, 2025
| Name | Region | Capital Pool |
|---|---|---|
| Brookfield Corporation | North America | Real Assets & Income |
| Brown & Brown, Inc. | North America | Compounding |
| Constellation Software Inc. | North America | Compounding |
| Royalty Pharma Plc Class A | North America | Real Assets & Income |
| Investor AB Class B | Europe | Real Assets & Income |
Regional Exposure
Capital Pools
Sector Exposure
Further Information
Looking for further information regarding the Fund, please don’t hesitate to get in touch: